论文信息 - Effect of a Ketohexokinase Inhibitor (PF‐06835919) on In Vivo OATP1B Activity: Integrative Risk Assessment Using Endogenous Biomarker and a Probe Drug - 字舞流文

Effect of a Ketohexokinase Inhibitor (PF‐06835919) on In Vivo OATP1B Activity: Integrative Risk Assessment Using Endogenous Biomarker and a Probe Drug

A. D. Rodrigues | M. Varma | A. Bergman | J. Litchfield | E. Kimoto | Y. Weng | M. Vourvahis | D. Tess | Kari R. Fonseca | V. Somayaji | Amanda J King-Ahmad | Ruolun Qui | Emi Kimoto | Amanda J. King-Ahmad